Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2012
10/16/2012US8288610 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/16/2012US8288608 Transgenic animal expressing alzheimer's tau protein
10/16/2012US8288572 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
10/16/2012US8288525 Compositions and methods for inhibiting expression of CD45 gene
10/16/2012US8288521 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
10/16/2012US8288520 Fast results hybrid capture assay and system
10/16/2012US8288519 Reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs
10/16/2012US8288518 Rearranged squamous cell carcinoma antigen genes
10/16/2012US8288517 Acid fungal proteases
10/16/2012US8288439 Attenuation of reproduction in human cells or transmission of infections ; using polynucleotide
10/16/2012US8288359 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
10/16/2012US8288358 Therapeutic targets and molecules
10/16/2012US8288356 MicroRNAs
10/16/2012US8288355 siRNA specific to WT1 17AA(−)isoform and use thereof
10/16/2012US8288322 Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
10/16/2012US8288160 Activation induced deaminase (AID)
10/16/2012US8288158 Stem cells modified to facilitate threonine catabolism
10/16/2012US8288156 Analytical chip and analyzer
10/16/2012US8288155 Biomolecular attachment sites on microelectronic arrays and methods thereof
10/16/2012US8288148 Compositions and methods for producing isoprene
10/16/2012US8288147 Host cells for production of isoprenoid compounds
10/16/2012US8288144 Mutants with improved detergent stability; use in the textile, detergent and cellulose fiber processing industries
10/16/2012US8288143 Cold-active beta-galactosidase, a method of producing same and use of such enzyme
10/16/2012US8288142 Hyaluronidase and method of use thereof
10/16/2012US8288140 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
10/16/2012US8288134 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors
10/16/2012US8288133 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors
10/16/2012US8288130 Polypeptide cleavage process
10/16/2012US8288127 Protein expression systems
10/16/2012US8288125 Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
10/16/2012US8288123 Methods and means relating to protein variants
10/16/2012US8288116 Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
10/16/2012US8288115 Method for enriching a prokaryotic DNA
10/16/2012US8288113 Method and device for protein delivery into cells
10/16/2012US8288107 Incorporating polynucleotides encoding fusion proteins comprising CFTR peptide and DNA binding domain of transcriptional activator that binds to site on detectable gene into host cell ; gene expressing; drug screening, high throughput assay; enhances dimerization of CFTR protein; cystic fibrosis
10/16/2012US8288104 Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same
10/16/2012US8288095 Methods and compositions for ordering restriction fragments
10/16/2012US8288093 Forming a nucleic acid invasive cleavage structure on a target sequence and cleaving the nucleic acid invasive cleavage structure in a site-specific manner; fluorescence in-situ hybridization detection of cytomegalo virus
10/16/2012US8288092 Modified nucleic acid polymers and methods for their production
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287883 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
10/16/2012US8287881 Synthetic gagpol genes and their uses
10/16/2012US8287878 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287871 Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012US8287854 Stem cell culture comprising aged keratinocytes for use in treatment and prevention of bone and insulin disorders
10/16/2012US8287852 Treatment of viral diseases with recombinant interferon α
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2536108C Compositions and methods for detecting and treating hereditary spastic paraplegia
10/16/2012CA2498465C Generation of plants with improved pathogen resistance
10/16/2012CA2484216C Preservation of rna and morphology in cells and tissues
10/16/2012CA2480696C Peptide epitopes common to antigens of the same multigene family
10/16/2012CA2480642C Lambda integrase mediated recombination in plants
10/16/2012CA2479512C Tissue engineering
10/16/2012CA2469492C Diagnostic methods for protein profiling
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2456120C Chondroitin synthase
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2419282C Method for accumulating foreign gene product at a high level in plant seeds
10/16/2012CA2418056C Methods for stable transformation of plants
10/16/2012CA2412498C Non-human animal models of tolerance to hepatitis c virus immunogenes
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2368357C Methods for treating congestive heart failure
10/16/2012CA2363911C Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
10/16/2012CA2357758C Dna encoding canine von willebrand factor and methods of use
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/16/2012CA2354103C Method for producing threonine and isoleucine
10/16/2012CA2285384C Simultaneous collection of dna and non-nucleic analytes from oral fluids
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139112A1 Ubiquitin fusions for improving the efficacy of cytosolic acting targeted toxins
10/11/2012WO2012139106A2 Herpes simplex virus
10/11/2012WO2012138939A1 New tale-protein scaffolds and uses thereof
10/11/2012WO2012138887A1 Chromosomal landing pads and related uses
10/11/2012WO2012138703A1 Axmi115 variant insecticidal gene and methods for its use
10/11/2012WO2012138629A2 Agrobacterium-mediated transformation of dicot plants
10/11/2012WO2012138613A1 Yarrowia n-alkane-hydroxylating cytochrome p450 promoter regions for gene expression in yeast
10/11/2012WO2012138591A1 pAVEC
10/11/2012WO2012138575A1 Compositions and methods for increasing muscle function and mass
10/11/2012WO2012138566A2 Genetic determinants of prostate and breast cancer risk
10/11/2012WO2012138453A1 Efficient protein expression in vivo using modified rna (mod-rna)
10/11/2012WO2012138289A1 Diagnosis and treatment of friedreich's ataxia
10/11/2012WO2012138223A2 Compounds and methods for altering activin receptor-like kinase signalling
10/11/2012WO2012138102A2 Dlk1-specific human antibodies and pharmaceutical composition containing same
10/11/2012WO2012138100A2 Activin receptor type ii b inhibitors comprising dlk1 extracellular water-soluble domain
10/11/2012WO2012137993A1 Antibodies against angiopoietins 1 and 2, and their use
10/11/2012WO2012137991A1 Pharmaceutical composition for the prevention or treatment of mucolipidosis ii, comprising a lysosomal enzyme as an active ingredient
10/11/2012WO2012137970A1 Modified laminin and use thereof
10/11/2012WO2012137967A1 Calcium phosphate microcapsule
10/11/2012WO2012137804A1 Method for determining oligonucleotide sequence
10/11/2012WO2012137689A1 Method for producing l-cysteine
10/11/2012WO2012137683A1 Recombinant polypeptide production method
10/11/2012WO2012137676A1 Novel anti-human il-23 receptor antibody
10/11/2012WO2012137449A1 Epo knockout gfp anemic mouse
10/11/2012WO2012137187A1 Novel expression and secretion vector systems for heterologous protein production in escherichia coli
10/11/2012WO2012137186A1 An in vitro method for high throughput screening of genotoxic agents in eukaryotic cells
10/11/2012WO2012137150A2 Cell penetrating peptides for intracellular delivery of molecules
10/11/2012WO2012137036A1 Cell penetrating peptides for intracellular delivery of molecules
1 ... 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 ... 4023